MSI-H CANCER
Clinical trials for MSI-H CANCER explained in plain language.
Never miss a new study
Get alerted when new MSI-H CANCER trials appear
Sign up with your email to follow new studies for MSI-H CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill tested to fight advanced cancers
Disease control Recruiting nowThis early-stage study is testing a new oral drug called NDI-219216 in patients with advanced solid tumors that have not responded to standard treatments. The main goals are to find a safe dose, understand how the drug works in the body, and see if it can shrink tumors. Participa…
Matched conditions: MSI-H CANCER
Phase: PHASE1, PHASE2 • Sponsor: Nimbus Wadjet, Inc. • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC
-
New hope for tough cancers: first human trial of experimental pill begins
Disease control Recruiting nowThis is the first human study testing a new oral drug called MOMA-341 for people with advanced solid tumors that have specific genetic features (MSI-H or dMMR). The main goal is to find safe doses and see how the body handles the drug when taken alone or combined with other cance…
Matched conditions: MSI-H CANCER
Phase: PHASE1 • Sponsor: MOMA Therapeutics • Aim: Disease control
Last updated Mar 17, 2026 13:09 UTC